MediBiofarma
Noáin
About MediBiofarma
Medibiofarma provides small molecule drugs for the treatment of cancer, activation of the immune system, treatment of non-cancer diseases, and target related diseases. They also provide drugs for life threatening conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Last round: Series Unknown (Apr 2024)
- Website: medibiofarma.com
Industries & Categories
Biotechnology, Health Care
Canonical: https://fsome.com/organization/medibiofarma-131424 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.